How can we improve adjuvant chemotherapy for colon cancer?

被引：0
|
作者：
Boku, Narikazu [1 ]
机构：
[1] St Marianna Univ, Sch Med, Dept Clin Oncol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 13期
关键词：
METASTATIC COLORECTAL-CANCER; 5-FLUOROURACIL; FLUOROURACIL; CAPECITABINE; OXALIPLATIN; SENSITIVITY; EXPRESSION; SURVIVAL; THERAPY; ENZYMES;
D O I：
10.1016/S1470-2045(14)71034-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1413 / 1415
页数：4
相关论文
共 50 条
  • [41] Optimal adjuvant chemotherapy completion time for stage III colon cancer: a cohort study
    Ren, Jing-Qing
    Zhang, Han-Shuo
    Zhang, Li-Hua
    Zhong, Qi-Guang
    Wu, Fan
    Wang, Bai-Lin
    Liu, Shao-Jie
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (04) : 1558 - 1567
  • [42] Cost-Effectiveness of Adjuvant FOLFOX and 5FU/LV Chemotherapy for Patients with Stage II Colon Cancer
    Ayvaci, Mehmet U. S.
    Shi, Jinghua
    Alagoz, Oguzhan
    Lubner, Sam J.
    MEDICAL DECISION MAKING, 2013, 33 (04) : 521 - 532
  • [43] Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan
    Minami, Kazuhito
    Morita, Masaru
    Emi, Yasunori
    Okamoto, Masahiro
    Tanaka, Eiji
    Nagata, Shigeyuki
    Touyama, Tetsuo
    Ohgaki, Kippei
    Tanaka, Takaho
    Okumura, Hiroshi
    Suenaga, Toyokuni
    Tokunaga, Shoji
    Oki, Eiji
    Kakeji, Yoshihiro
    Akagi, Yoshito
    Baba, Hideo
    Natsugoe, Shoji
    Maehara, Yoshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (03) : 505 - 510
  • [44] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
  • [45] Adjuvant Chemotherapy for Stage III Colon Cancer: Does Timing Matter?
    Czaykowski, Piotr M.
    Gill, Sharlene
    Kennecke, Hagen F.
    Gordon, Vallerie L.
    Turner, Donna
    DISEASES OF THE COLON & RECTUM, 2011, 54 (09) : 1082 - 1089
  • [46] Duration of Adjuvant Chemotherapy in Colon Cancer: Current Standards and New Updates
    Greally, Megan
    Ilson, David H.
    CURRENT COLORECTAL CANCER REPORTS, 2019, 15 (04) : 122 - 129
  • [47] OPINION DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer
    Sinicrope, Frank A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (03) : 174 - 177
  • [48] Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer
    Chang, H. J.
    Lee, K. -W.
    Kim, J. H.
    Bang, S. M.
    Kim, Y. J.
    Kim, D. W.
    Kang, S. B.
    Lee, J. S.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 911 - 918
  • [49] Impact of Anatomic Extent of Nodal Metastasis on Adjuvant Chemotherapy Outcomes in Stage III Colon Cancer
    Woo, In Teak
    Park, Jun Seok
    Kang, Byung Woog
    Park, Soo Yeun
    Kim, Hye Jin
    Choi, Gyu-Seog
    Gwang Kim, Jong
    DISEASES OF THE COLON & RECTUM, 2020, 63 (10) : 1455 - 1465
  • [50] Does Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer Really Save Lives?
    Wong, Hui-li
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) : 511 - 512
12345